Charles River Laboratories International CRL
NYSE CRL
$350.80 +12.26 (+3.62%)
As of: Nov 3, 2026 · 3:59 PM EST

Charles River Laboratories International (CRL) Current Deferred Tax Assets (2010 - 2011)

Updated

Charles River Laboratories International (CRL) posted Current Deferred Tax Assets of $28.52 million for Q3 2011, up 22.4% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

At the end of FY2010, Charles River Laboratories International's Current Deferred Tax Assets came in at $31.25 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.58 Bn 33.96 Bn 1.50 Bn
2 Medpace Holdings 18.13 Bn 15.77 Bn 223.89 Mn
3 Charles River Laboratories International 16.15 Bn 15.39 Bn 363.37 Mn
4 Icon 15.71 Bn 12.48 Bn 491.83 Mn
5 Fortrea Holdings 1.93 Bn 1.22 Bn 139.50 Mn
6 Ginkgo Bioworks Holdings 627.55 Mn -134.53 Mn 18.44 Mn
7 Evotec SE 540.45 Mn -1.07 Bn -
8 Champions Oncology 68.48 Mn 44.13 Mn 7.70 Mn
9 MindWalk Holdings 51.38 Mn 15.04 Mn 1.61 Mn
10 Natural Alternatives International 6.45 Mn -21.63 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 24, 2011 28.52 Mn
Jun 25, 2011 23.29 Mn
Dec 25, 2010 31.25 Mn
API Access

Charles River Laboratories International Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=CRL&period=max&api_key=YOUR_API_KEY